Bicara Therapeutics (BCAX) Institutional Ownership $11.90 -0.04 (-0.34%) Closing price 04:00 PM EasternExtended Trading$11.90 -0.01 (-0.04%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Bicara Therapeutics (NASDAQ:BCAX)Number ofInstitutional Buyers(last 12 months)85TotalInstitutional Inflows(last 12 months)$676.26MNumber ofInstitutional Sellers(last 12 months)11TotalInstitutional Outflows(last 12 months)$20.29M Get BCAX Insider Trade Alerts Want to know when executives and insiders are buying or selling Bicara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data BCAX Institutional Buying and Selling by Quarter Bicara Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Tower Research Capital LLC TRC 4,788$44K0.0%+419.3%0.009% 8/15/2025 Vestal Point Capital LP5,000,000$46.45M2.4%+80.6%9.164% 8/15/2025 BNP Paribas Financial Markets3,168$29K0.0%-85.3%0.006% 8/15/2025 Bank of America Corp DE451,228$4.19M0.0%+2,351.0%0.827% 8/15/2025 Ameriprise Financial Inc.16,090$149K0.0%N/A0.029% 8/14/2025 Jane Street Group LLC28,604$266K0.0%N/A0.052% 8/14/2025 Raymond James Financial Inc.67,701$629K0.0%N/A0.124% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.18,729$174K0.0%+64.7%0.034% 8/14/2025 The Manufacturers Life Insurance Company 125,783$1.17M0.0%+83.5%0.231% 8/13/2025 SCS Capital Management LLC53,430$496K0.0%N/A0.098% Get the Latest News and Ratings for BCAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bicara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/13/2025 Marshall Wace LLP51,809$481K0.0%N/A0.095% 8/13/2025 Walleye Capital LLC24,308$226K0.0%N/A0.045% 8/13/2025 Invesco Ltd.16,877$157K0.0%+13.2%0.031% 8/13/2025 New York State Common Retirement Fund26,094$242K0.0%+552.4%0.048% 8/13/2025 Schroder Investment Management Group425,341$3.95M0.0%+921.0%0.780% 8/13/2025 Skandinaviska Enskilda Banken AB publ 99,236$922K0.0%+160.9%0.182% 8/13/2025 Virtus Investment Advisers LLC8,127$76K0.0%-10.7%0.015% 8/13/2025 Norges Bank42,889$398K0.0%N/A0.079% 8/13/2025 Russell Investments Group Ltd.27,472$255K0.0%N/A0.050% 8/12/2025 XTX Topco Ltd32,414$301K0.0%+13.9%0.059% 8/12/2025 Ameritas Investment Partners Inc.3,493$32K0.0%+73.0%0.006% 8/12/2025 American Century Companies Inc.11,096$103K0.0%N/A0.020% 8/12/2025 Rhumbline Advisers46,911$436K0.0%+103.8%0.086% 8/12/2025 Legal & General Group Plc3,156$29K0.0%+64.1%0.006% 8/12/2025 JPMorgan Chase & Co.27,458$255K0.0%+26.0%0.050% 8/12/2025 Artisan Partners Limited Partnership402,765$3.74M0.0%N/A0.738% 8/8/2025 Intech Investment Management LLC27,673$257K0.0%+65.3%0.051% 8/8/2025 Police & Firemen s Retirement System of New Jersey8,109$75K0.0%+119.6%0.015% 8/8/2025 Geode Capital Management LLC672,485$6.25M0.0%+36.8%1.233% 8/8/2025 Nan Fung Trinity HK Ltd.342,885$3.19M0.4%N/A0.629% 7/28/2025 TD Asset Management Inc224,538$2.09M0.0%+71.5%0.412% 7/14/2025 Atle Fund Management AB147,380$1.37M0.6%+23.0%0.270% 5/29/2025 Rhumbline Advisers23,018$300K0.0%+21.1%0.042% 5/16/2025 Woodline Partners LP348,690$4.54M0.0%+26.5%0.639% 5/16/2025 Goldman Sachs Group Inc.125,695$1.64M0.0%-30.1%0.230% 5/16/2025 AQR Capital Management LLC19,034$248K0.0%N/A0.035% 5/16/2025 Adage Capital Partners GP L.L.C.1,182,900$15.41M0.0%-45.6%2.169% 5/15/2025 Vestal Point Capital LP2,768,975$36.08M2.6%+290.0%5.077% 5/15/2025 Braidwell LP2,162,803$28.18M1.0%+8.1%3.966% 5/15/2025 DAFNA Capital Management LLC212,001$2.76M0.8%+100.9%0.389% Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again.5/15/2025 Siren L.L.C.3,267,083$42.57M2.5%-0.2%5.991% 5/14/2025 Wellington Management Group LLP1,394,676$18.17M0.0%+84.0%2.557% 5/12/2025 Nuveen LLC25,028$326K0.0%N/A0.046% 5/9/2025 Deutsche Bank AG111,383$1.45M0.0%-1.0%0.204% 5/9/2025 Charles Schwab Investment Management Inc.153,004$1.99M0.0%-2.4%0.281% 5/8/2025Jefferies Financial Group Inc.30,601$399K0.0%N/A0.056% 5/8/2025 XTX Topco Ltd28,453$371K0.0%+4.1%0.052% 5/8/2025 Federated Hermes Inc.12,000$156K0.0%+50.0%0.022% 5/7/2025 TD Asset Management Inc130,938$1.71M0.0%+27.8%0.240% 5/5/2025 Atle Fund Management AB119,833$1.56M0.7%N/A0.220% 5/2/2025 Victory Capital Management Inc.34,430$449K0.0%N/A0.063% 5/1/2025 CWM LLC2,198$29K0.0%N/A0.004% 5/1/2025 New York State Common Retirement Fund4,000$52K0.0%N/A0.007% 4/29/2025 Bank of New York Mellon Corp42,192$550K0.0%+4.8%0.077% 4/15/2025 Avanza Fonder AB6,653$88K0.0%N/A0.012% 4/8/2025 Rhumbline Advisers23,018$300K0.0%+21.1%0.042% 4/7/2025 GAMMA Investing LLC7,753$101K0.0%+13,040.7%0.014% 3/24/2025 Wellington Management Group LLP757,968$13.20M0.0%-0.8%1.393% 3/18/2025 California State Teachers Retirement System1,426$25K0.0%N/A0.003% 2/17/2025 Woodline Partners LP275,692$4.80M0.0%-0.8%0.507% 2/17/2025 Vestal Point Capital LP710,000$12.37M0.7%+67.1%1.305% 2/17/2025 Wexford Capital LP20,000$348K0.1%N/A0.037% 2/17/2025 Red Tree Management LLC3,170,509$55.23M36.3%N/A5.826% 2/17/2025Nuveen Asset Management LLC25,028$436K0.0%N/A0.046% 2/17/2025 Orbimed Advisors LLC298,301$5.20M0.1%+9.7%0.548% 2/17/2025 Maven Securities LTD25,000$436K0.0%-50.0%0.046% 2/17/2025 Millennium Management LLC385,406$6.71M0.0%+28.7%0.708% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.10,907$190K0.0%N/A0.020% 2/17/2025 LMR Partners LLP15,150$264K0.0%N/A0.028% 2/17/2025 Janus Henderson Group PLC863,846$15.01M0.0%-27.3%1.587% 2/17/2025 Deutsche Bank AG112,476$1.96M0.0%N/A0.207% 2/17/2025 DAFNA Capital Management LLC105,500$1.84M0.5%N/A0.194% 2/17/2025 Deep Track Capital LP2,000,000$34.84M1.3%+151.0%3.675% 2/17/2025 Braidwell LP2,000,659$34.85M1.0%+20.7%3.676% 2/17/2025 Blackstone Inc.913,060$15.91M0.1%+40.5%1.678% 2/17/2025 Bank of America Corp DE33,677$587K0.0%+278.4%0.062% 2/17/2025 BNP Paribas Financial Markets1,830$32K0.0%N/A0.003% 2/17/2025 Acorn Capital Advisors LLC643,381$11.21M6.1%N/A1.182% 2/14/2025 Boxer Capital Management LLC135,000$2.35M0.2%N/A0.248% 2/14/2025 Foresite Capital Management VI LLC950,000$16.55M7.4%N/A1.746% 2/14/2025 Northern Trust Corp159,043$2.77M0.0%N/A0.292% 2/14/2025 The Manufacturers Life Insurance Company29,138$508K0.0%+27.5%0.054% 2/14/2025 Virtus ETF Advisers LLC3,939$69K0.0%N/A0.007% 2/14/2025 Adage Capital Partners GP L.L.C.2,175,265$37.89M0.1%+171.9%3.997% 2/14/2025 Price T Rowe Associates Inc. MD1,547,180$26.95M0.0%+0.5%2.843% 2/14/2025 MetLife Investment Management LLC12,163$212K0.0%N/A0.022% 2/13/2025 Marshall Wace LLP67,733$1.18M0.0%N/A0.124% 2/13/2025 XTX Topco Ltd27,334$476K0.0%N/A0.050% 2/13/2025 Barclays PLC30,107$524K0.0%+201.1%0.055% 2/13/2025 Summit Investment Advisors Inc.2,019$35K0.0%N/A0.004% Google did what!?!? (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why2/13/2025 Legal & General Group Plc1,923$33K0.0%N/A0.004% 2/13/2025 Invesco Ltd.15,324$267K0.0%N/A0.028% 2/13/2025 Wells Fargo & Company MN10,027$175K0.0%N/A0.018% 2/12/2025 Cinctive Capital Management LP16,984$296K0.0%+88.7%0.031% 2/12/2025 Geode Capital Management LLC466,642$8.13M0.0%+859.4%0.857% 2/12/2025 Alliancebernstein L.P.821,264$14.31M0.0%+16.0%1.509% 2/12/2025 Wellington Management Group LLP757,968$13.20M0.0%-0.8%1.393% 2/12/2025 Norges Bank70,000$1.22M0.0%N/A0.129% 2/12/2025 JPMorgan Chase & Co.64,740$1.13M0.0%+8,768.5%0.119% 2/11/2025 Corebridge Financial Inc.9,597$167K0.0%N/A0.018% (Data available from 1/1/2016 forward) BCAX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BCAX shares? During the previous two years, 88 institutional investors and hedge funds held shares of Bicara Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($177.17M), FMR LLC ($57.91M), Red Tree Management LLC ($55.23M), Vestal Point Capital LP ($46.45M), Siren L.L.C. ($42.57M), Deep Track Capital LP ($34.84M), and Braidwell LP ($28.18M).Learn more on Bicara Therapeutics' institutional investors. Which institutional investors have been buying Bicara Therapeutics' stock? Of the 85 institutional investors that purchased Bicara Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($6.96M), Vestal Point Capital LP ($5M), Red Tree Management LLC ($3.17M), FMR LLC ($2.27M), Braidwell LP ($2.16M), Wellington Management Group LLP ($1.40M), and Adage Capital Partners GP L.L.C. ($1.38M). How much institutional buying is happening at Bicara Therapeutics? Institutional investors have bought a total of 34,623,338 shares in the last 24 months. This purchase volume represents approximately $676.26M in transactions. Which of Bicara Therapeutics' major shareholders have been selling company stock? Of the 11 institutional investors that sold Bicara Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($992.37K), Janus Henderson Group PLC ($324.35K), Goldman Sachs Group Inc. ($54.05K), Maven Securities LTD ($25K), BNP Paribas Financial Markets ($18.35K), Wellington Management Group LLP ($11.95K), and Siren L.L.C. ($5.74K). How much institutional selling is happening at Bicara Therapeutics? Institutional investors have sold a total of 1,439,927 shares in the last 24 months. This volume of shares sold represents approximately $20.29M in transactions. Related Companies CPRX Institutional Ownership ALVO Institutional Ownership KNSA Institutional Ownership OGN Institutional Ownership TARS Institutional Ownership CNTA Institutional Ownership DNLI Institutional Ownership AGIO Institutional Ownership IDYA Institutional Ownership IBRX Institutional Ownership This page (NASDAQ:BCAX) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicara Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCAX Stock Alerts